Why the incidence of post-ERCP pancreatitis varies considerably? Factors affecting the diagnosis and the incidence of this complication

Journal of the Pancreas

Volumn 3, Issue 6, 2002, Pages 195-201

  Testoni, Pier Alberto ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Acute disease; Amylases; Cholangiopancreatography; Endoscopic; Endoscopic retrograde; Epidemiology; Pancreatitis; Risk factors; Sphincterotomy

Indexed keywords

AMYLASE; BILIRUBIN;

ABDOMINAL PAIN; ARTICLE; BILE DUCT DILATATION; CANNULATION; COMPUTER ASSISTED TOMOGRAPHY; CONSENSUS DEVELOPMENT; DISEASE DURATION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; GENDER; HUMAN; HYPERAMYLASEMIA; INCIDENCE; INFORMATION PROCESSING; MALE; MANOMETRY; MEDICAL EXPERT; ODDI SPHINCTER; PANCREAS DISEASE; PANCREATITIS; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; VATER PAPILLOTOMY; REVIEW;

CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; HUMANS; INCIDENCE; PANCREATITIS; RISK FACTORS;

EID: 0036833454     PISSN: 15908577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Gottlieb K, Sherman S. ERCP and endoscopic biliary sphincterotomy-induced pancreatitis. Gastrointest Endosc Clin N Am 1998; 8:87-114. [AN 98070870]
2. Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RCG, Meyers WC, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991; 37:383-93. [AN 91301427]
3. Sherman S, Hawes RH, Rathgaber SW, Uzer MF, Smith MT, Khusro QE, et al. Post-ERCP pancreatitis: randomized, prospective study comparing a low- and high-osmolality contrast agent. Gastrointest Endosc 1994; 40:422-7. [AN 95011329]
4. Testoni PA, Cicardi M, Bergamaschini L, Guzzoni S, Cugno M, Buizza M, et al. Infusion of C1-inhibitor plasma concentrate prevents hyperamylasemia induced by endoscopic sphincterotomy. Gastrointest Endosc 1995; 42:301-5. [AN 96121319]
5. Weiner GR, Geenen JE, Hogan WJ, Catalano MF. Use of corticosteroids in the prevention of post-ERCP pancreatitis. Gastrointest Endosc 1995; 42:579-83. [AN 96235838]
6. Cavallini G, Tittobello A, Frulloni L, Masci E, Mariani A, Di Francesco V, et al. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. N Engl J Med 1996; 335:919-23. [AN 96365276]
7. Tanner AR. ERCP: present practice in a single region. Suggested standards for monitoring performance. Eur J Gastroenterol Hepatol 1996; 8:145-8. [AN 96309135]
8. Testoni PA, Lella F, Bagnolo F, Caporuscio S, Cattani L, Colombo E, Buizza M. Long-term prophylactic administration of octreotide reduces the rise in serum amylase after endoscopic procedures on Vater's papilla. Pancreas 1996; 13:61-5. [AN 96377495]
9. Johnson GK, Geenen JE, Johanson JF, Sherman S, Hogan WJ, Cass O. Evaluation of post-ERCP pancreatitis: potential causes noted during controlled study of differing contrast media. Midwest Pancreaticobiliary Study Group. Gastrointest Endosc 1997; 46:217-22. [AN 98017979]
10. Messmann H, Vogt W, Holstege A, Lock G, Heinisch A, von Furstenberg A, et al. Post-ERCP pancreatitis as a model for cytokine induced acute phase response in acute pancreatitis. Gut 1997; 40:80-5. [AN 97300559]
11. Testoni PA, Bagnolo F. Pain at 24 hours associated with amylase levels greater than 5 times the upper normal limit as the most reliable indicator of post-ERCP pancreatitis. Gastrointest Endosc 2001; 53:33-9. [AN 21067928]
12. Deviere J, Le Moine O, Van Laethem JL, Eisendrath P, Ghilain A, Severs N, Cohard M. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 2001; 120:498-505. [AN 21100083]
13. Rabenstein T, Roggenbuck S, Framke B, Martus P, Fischer B, Nusko G, et al. Complications of endoscopic sphincterotomy: can heparin prevent acute pancreatitis after ERCP? Gastrointest Endosc 2002; 55:476-83. [AN 21920675]
14. Manolakopoulos S, Avgerinos A, Vlachogiannakos J, Armonis A, Viazis G, Papadimitriou N, et al. Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial. Gastrointest Endosc 2002; 55:470-5. [AN 21920674]
15. Prat F, Amaris J, Ducot B, Bocquentin M, Fritsch J, Choury AD, et al. Nifedipine for prevntion of post-ERCP pancreatitis: a prospective, double-blind randomized trial. Gastrointest Endosc 2002; 56:202-8. [AN 22140167]
16. Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996; 335:909-18. [AN 96365275]
17. Loperfido S, Angelini G, Benedetti G, Chilovi F, Costan F, De Berardinis F, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 1998; 48:1-10. [AN 98347799]
18. Masci E, Toti G, Mariani A, Curioni S, Lomazzi A, Dinelli M, et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol 2001; 96:417-23. [AN 21122345]
19. Freeman ML, DiSario JA, Nelson DB, Fennerty MB, Lee JG, Bjorkman DJ, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 2001; 54:425-34. [AN 21460528]
20. Neoptolemos JP, Bailey IS, Carr-Locke DL. Sphincter of Oddi dysfunction: results of treatment by endoscopic sphincterotomy. Br J Surg 1988; 75:454-9. [AN 88269979]
21. Sherman S, Ruffolo TA, Hawes RH, Lehman GA. Complications of endoscopic sphincterotomy. A prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and nondilated bile ducts. Gastroenterology 1991; 101:1068-75. [AN 91365172]
22. Chen YK, Foliente RL, Santoro MJ, Walter MH, Collen MJ. Endoscopic sphincterotomy-induced pancreatitis: increased risk associated with nondilated bile ducts and sphincter of Oddi dysfunction. Am J Gastroenterol 1994; 89:327-33. [AN 94168165]
23. Tarnasky PR, Palesch YY, Cunningham JT, Mauldin PD, Cotton PB, Hawes RH. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology 1998; 115:1518-24. [AN 99055594]
24. Maldonado ME, Brady PG, Mamel JJ, Robinson B. Incidence of pancreatitis in patients undergoing sphincter of Oddi manometry (SOM). Am J Gastroenterol 1999; 94:387-90. [AN 99145232]
25. Tarnasky P, Cunningham J, Cotton P, Hoffman B, Palesch Y, Freeman J, et al. Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis. Endoscopy 1997; 29:252-7. [AN 97399400]
26. Johnson GK, Cass O, Geenen JA, Lehman GA, Frakes J, Ryan M, et al. Post-ERCP pancreatitis: a comparative study of patients with and without pancreatic duct injection at the time of ERCP. Gastrointest Endosc 1993; 39:319.
27. Rabenstein T, Schneider HT, Nicklas M, Ruppert T, Katalinic A, Hahn EG, Ell C. Impact of skill and experience of the endoscopist on the outcome of endoscopic sphincterotomy techniques. Gastrointest Endosc 1999; 50:628-36. [AN 20007795]
28. Hellier MD, Morris AI. ERCP-training - time for change. Gut 2000; 47:459-60. [AN 20444117]
29. Eisen GM, Dominitz JA, Faigel DO, Goldstein JL, Kalloo AN, Petersen BT, et al. Guidelines for advanced endoscopic training. Gastrointest Endosc 2001; 53:846-8. [AN 21269173]
30. Petersen BT. ERCP outcomes: defining the operators, experience, and environments. Gastrointest Endosc 2002; 55:953-8. [AN 22021254]
31. Johnson JF, Cooper G, Eisen GM, Freeman M, Goldstein JL, Jensen DM, et al. Quality assessment of ERCP. Endoscopic retrograde cholangiopacreatography. Gastrointest Endosc 2002; 56:165-9. [AN 22140161]
32. Harewood GC, Baron TH. An assessment of the learning curve for precut biliary sphincterotomy. Am J Gastroenterol 2002; 97:1708-12. [AN 22130045]
33. Gottlieb K, Sherman S, Pezzi J, Esber E, Lehman GA. Early recognition of post-ERCP pancreatitis by clinical assessment and serum pancreatic enzymes. Am J Gastroenterol 1996; 91:1553-7. [AN 96322170]
34. Testoni PA, Bagnolo F, Natale V, Primignani M. Incidence of post-endoscopic retrograde- cholangiopancreatography/sphincterotomy pancreatitis depends upon definition criteria. Dig Liver Dis 2000; 32:412-8. [AN 20483104]
35. Bradley EL 3rd. A clinically-based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg 1993; 128: 586-90. [AN 93256758]